Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

BACKGROUND: Nitazoxanide exerts antiviral activity in vitro and in vivo and anti-inflammatory effects, but its impact on patients hospitalized with COVID-19 pneumonia is uncertain. METHODS: A multicentre, randomized, double-blind, placebo-controlled trial was conducted in 19 hospitals in Brazil. Hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocco, Patricia R. M., Silva, Pedro L., Cruz, Fernanda F., Tierno, Paulo F. G. M. M., Rabello, Eucir, Junior, Jéfiton Cordeiro, Haag, Firmino, de Ávila, Renata E., da Silva, Joana D. G., Mamede, Mariana M. S., Buchele, Konrad S., Barbosa, Luiz C. V., Cabral, Anna C., Junqueira, Antônio A. F., Araújo-Filho, João A., da Costa, Lucianna A. T. J., Alvarenga, Pedro P. M., Moura, Alexandre S., Carajeleascow, Ricardo, de Oliveira, Mirella C., Silva, Roberta G. F., Soares, Cynthia R. P., Fernandes, Ana Paula S. M., Fonseca, Flavio Guimarães, Camargos, Vidyleison Neves, Reis, Julia de Souza, Franchini, Kleber G., Luiz, Ronir R., Morais, Sirlei, Sverdloff, Carlos, Martins, Camila Marinelli, Felix, Nathane S., Mattos-Silva, Paula, Nogueira, Caroline M. B., Caldeira, Dayene A. F., Pelosi, Paolo, Lapa-e-Silva, José R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043450/
https://www.ncbi.nlm.nih.gov/pubmed/35492335
http://dx.doi.org/10.3389/fmed.2022.844728

Ejemplares similares

Ejemplares similares